CClinicalTrials.gg
TerminatedNCT03997487Updated Aug 22, 2022

Smartphone App for Taking Images of Conjunctivae

An interventional study of TOFTEE in Trachoma, sponsored by London School of Hygiene and Tropical Medicine. Terminated at 1 site in Tanzania. Open to participants aged 1 Year and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-08-22.

Sponsored by London School of Hygiene and Tropical Medicine · Not applicable, Interventional, and Other

Why this study was terminated
Lack of funding
Phase
Not applicable
Study type
Interventional
Enrollment
125
Allocation
Not applicable
Ages
1 Year and older
Sex
All
01

Study summary

Trachomatous inflammation-follicular (TF) is diagnosed by looking for clinical signs of infection of everted eyelids (conjunctivae) of children.

The overall objective of this project is to develop a smartphone application and assess its acceptability and feasibility.

Fieldwork will take place during routine Tropical Data trainings and population-based prevalence surveys supported by Tropical Data.

Healthy adult volunteers in London will have photos of their conjunctivae taken to develop the app initially, with iterative improvements to the app based on image quality achieved. For fieldwork, images of the conjunctivae of children will be have photos of their conjunctivae taken with a digital single lens reflex (DSLR) camera and the newly developed smartphone app. Grading of the photos will be compared with field grading, to compare grading agreement, to assess utility for supervision, quality assurance and training purposes.

Read the detailed description

The investigators want to see whether it would be possible to take photos using Android smartphones, routinely used in trachoma surveys for collecting data, for quality assurance, supervision and training purposes. The investigators will develop an app in the United Kingdom (UK) by taking photos of the conjunctivae of healthy adult volunteers to iteratively improve the quality of images based on the image metadata and review by trachoma experts. The app will then be field tested, and trachoma grading based on the app photos, DSLR photos, and clinical grading, compared. Any management (treatment) will be based on routine clinical diagnosis only - the images are for research purposes only. The investigators will also ask participants for their views on acceptability of having photos of conjunctivae taken with the phone, and conduct a cost-consequences analysis of potential implementation of the app in routine trachoma surveys.

Objectives and approach:

2.1 To develop a mobile phone application to capture images of everted eyelids (conjunctivae) of children being examined as part of the Tropical Data field inter-grader agreement (IGA) test, or sampled as part of trachoma prevalence surveys.

2.2 To evaluate the quality of the mobile phone application images compared with field grading and DSLR images.

2.3 To assess the acceptability and feasibility of a mobile phone application for photographing everted eyelids (conjunctivae) from children being examined as part of the Tropical Data IGA test, or sampled as part of trachoma prevalence surveys.

2.4 To conduct a cost-consequences analysis of setting up an infrastructure for capturing and transmitting images in order to make the system economically viable.

02

Conditions studied

  • Trachoma

Browse trials for

03

Who can participate

Ages eligible
1 Year and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Objectives 2.1 and 2.2:

  • For the London-based app development, any eligible healthy adult who provides written informed consent will be eligible.
  • For the field-based app development, any child aged 1-9 years being examined as part of the Tropical Data IGA test, or sampled as part of trachoma prevalence surveys, and for whom written informed consent has been provided by a guardian, will be eligible.

Objective 2.3:

  • All Tropical Data trainers and trainees attending the Tropical Data (initial and refresher) training events and who provide written informed consent, will be eligible.
  • Community leaders and children's guardians who provide written informed consent will be eligible.

Exclusion criteria

Exclusion Criteria:

  • For each of the objectives, if the inclusion criteria are not fulfilled, the participant will not be eligible to participate.
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
125 participants (actual)

Study arms

  • Experimental
    Children examined

    All children examined for clinical signs of trachoma will be invited to participate to have photos of conjunctivae taken with the TOFTEE smartphone app and a DSLR camera.

    Other: TOFTEE

Interventions

  • OtherTOFTEE

    Smartphone app for taking quality images of conjunctivae

05

What researchers measure

Primary outcomes

  1. TOols For Trachoma Elimination Endgame (TOFTEE) app image quality

    Photo quality will be assessed by trachoma grading experts. The technical parameters such as lighting, resolution, focus, etc. will be assessed using objective software or extracted from the photograph metadata.

    Time frame: 30 minutes

  2. Kappa score of TOFTEE image compared with field grading

    Concordance in diagnosis of trachoma between field grading and app image

    Time frame: 5 minutes

  3. Kappa score of TOFTEE image compared with DSLR grading

    Concordance in diagnosis of trachoma between app image and DSLR image

    Time frame: 5 minutes

  4. Kappa score of DSLR image compared with field grading

    Concordance in diagnosis of trachoma between field grading and DSLR image

    Time frame: 5 minutes

Secondary outcomes

  1. Association (reported as proportions, unadjusted and adjusted odds ratios) between child characteristics and TOFTEE image quality

    Association (reported as proportions, unadjusted and adjusted odds ratios) between child characteristics acceptable photo quality

    Time frame: 15 minutes

  2. Acceptability and feasibility of TOFTEE app in communities

    Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of TOFTEE app in communities

    Time frame: 45 minutes

  3. Acceptability and feasibility of TOFTEE app in Tropical Data system

    Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of TOFTEE app as part of the Tropical Data system

    Time frame: 45 minutes

  4. Cost of TOFTEE app implementation

    Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of TOFTEE app implementation into the Tropical Data system

    Time frame: 5 days

06

Study locations

1 site
  • Arusha region
    Arusha, Tanzania
07

References and documents

Individual participant data

Plan to share: Yes — Anonymised data will be shared with relevant study team members for the purposes of data analysis. Data Transfer Agreements will be completed, where appropriate.

Supporting information: Study protocol

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03997487
Lead sponsor
London School of Hygiene and Tropical Medicine
Collaborators
National Institute for Medical Research, Tanzania, Federal Minstry of Health of Ethiopia, Jos University Teaching Hospital, University College London Hospitals, RTI International, Sightsavers, World Health Organization, Pan American Health Organization
Responsible party
Sponsor
First posted
Jun 25, 2019
Start date
Jul 8, 2019
Primary completion
Jul 12, 2019
Completion
Jul 12, 2019
Last update
Aug 22, 2022

Study contacts

Emma Harding-Esch
principal investigator · London School of Hygiene and Tropical Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion